Akebia Therapeutics reported $26.12M in Equity Capital and Reserves for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US $ 444.8M 96.1M
Agios Pharmaceuticals AGIO:US $ 1207.45M 84.52M
Akebia Therapeutics AKBA:US $ 26.12M 50.34M
Alnylam Pharmaceuticals ALNY:US $ 401.17M 187.04M
Amgen AMGN:US $ 916M 5784M
Ardelyx ARDX:US $ 64.19M 18.43M
Astellas Pharma 4503:JP Y 1460308M 5983M
AstraZeneca AZN:LN 36340M 2928M
Avrobio Inc AVRO:US $ 143.16M 26.31M
Bayer BAYN:GR € 33020M 1917M
Biomarin Pharmaceutical BMRN:US $ 4391.31M 120.58M
Exelixis EXEL:US $ 2293.85M 83.24M
Fresenius Medical Care FME:GR € 13234.5M 535.71M
Ironwood Pharmaceuticals IRWD:US $ 517.78M 88.13M
Karyopharm Therapeutics KPTI:US $ -83079000 3.41M
Lexicon Pharmaceuticals LXRX:US $ 92.7M 20.9M
Nektar Therapeutics NKTR:US $ 679.51M 122.03M
Prothena PRTA:US $ 438.89M 27.16M